Reduced asymmetric dimethylarginine (ADMA) levels mediate in the protection from metabolic syndrome by smoking

被引：6
|
作者：
Onat, Altan [2 ]
Hergenc, Guelay [1 ]
机构：
[1] Yildiz Tech Univ, Dept Biol, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey
来源：
ATHEROSCLEROSIS | 2008年 / 196卷 / 01期
关键词：
asymmetric dimethylarginine; cigarette smoking; insulin resistance; metabolic syndrome; obesity;
D O I：
10.1016/j.atherosclerosis.2006.10.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：479 / 480
页数：2
相关论文
共 50 条
  • [1] Asymmetric dimethylarginine (ADMA), a marker of endothelial dysfunction levels in metabolic syndrome
    Avci, Emre
    Avci, Gulcin Alp
    Cevher, Sule Coskun
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 120 : S148 - S148
  • [2] Plasma concentrations of asymmetric dimethylarginine (ADMA) in metabolic syndrome
    Garcia, Ronald G.
    Perez, Maritza
    Maas, Renke
    Schwedhelm, Edzard
    Boeger, Rainer H.
    Lopez-Jaramillo, Patricio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 (02) : 176 - 178
  • [3] Cigarette smoking lowers asymmetric dimethylarginine (ADMA) levels influence of dimethylarginine dimethylaminohydrolase (DDAH)
    Schulze, F.
    Hamraz, K.
    Maas, R.
    Schwedhelm, E.
    Boger, R. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 115 - 115
  • [4] Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome
    Palomo, Ivan
    Contreras, Alejandra
    Marcelo Alarcon, L.
    Leiva, Elba
    Guzman, Luis
    Mujica, Veronica
    Icaza, Gloria
    Diaz, Nora
    Gonzalez, Daniel R.
    Moore-Carrasco, Rodrigo
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2011, 24 (04): : 224 - 228
  • [5] Asymmetric dimethylarginine (ADMA) may mediate and reflect improvement of endothelial function by short-term exercise training in metabolic syndrome
    Casella-Filho, A.
    Trombetta, I. C.
    Gomes, V. A.
    Cesena, F. Y.
    Landim, M. P.
    Oliveira, S. F.
    Tanus-Santos, J. E.
    Negrao, C. E.
    Daluz, P. L.
    Chagas, A. C. P.
    EUROPEAN HEART JOURNAL, 2008, 29 : 491 - 491
  • [6] High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis
    Zafer Mengeloglu
    Mahmut Sünnetcioglu
    Mehmet Tosun
    Abdülkadir Kücükbayrak
    Mehmet Resat Ceylan
    Ali Irfan Baran
    Mustafa Karahocagil
    Hayrettin Akdeniz
    Inflammation, 2014, 37 : 127 - 131
  • [7] High Asymmetric Dimethylarginine (ADMA) Levels in Patients with Brucellosis
    Mengeloglu, Zafer
    Sunnetcioglu, Mahmut
    Tosun, Mehmet
    Kucukbayrak, Abdulkadir
    Ceylan, Mehmet Resat
    Baran, Ali Irfan
    Karahocagil, Mustafa
    Akdeniz, Hayrettin
    INFLAMMATION, 2014, 37 (01) : 127 - 131
  • [8] Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS)
    Ozgurtas, Taner
    Oktenli, Cagatay
    Dede, Murat
    Tapan, Serkan
    Kenar, Levent
    Sanisoglu, S. Yavuz
    Yesilova, Zeki
    Yenen, Mufit C.
    Erbil, M. Kemal
    Baser, Iskender
    ATHEROSCLEROSIS, 2008, 200 (02) : 336 - 344
  • [9] Increased Circulating Asymmetric Dimethylarginine (ADMA) Levels in the Active Stage of Behcet's Syndrome
    Terekeci, H. M.
    Nalbant, S.
    Ozgurtas, T.
    Celik, S.
    Tapan, S.
    Sanisoglu, Y. S.
    Sahan, B.
    Sayan, O.
    Kucukardali, Y.
    Top, C.
    Oktenli, C.
    AKTUELLE RHEUMATOLOGIE, 2009, 34 (02) : 121 - 125
  • [10] Asymmetric dimethylarginine (ADMA) plasma levels in pediatric obstructive sleep APNEA syndrome (OSAS)
    Serpero, L. D.
    Sans Capdevila, O.
    Kheirandish, L.
    Tauman, R.
    Gozal, D.
    SLEEP, 2006, 29 : A70 - A70
12345